THER Stock - Theralink Technologies, Inc.
Unlock GoAI Insights for THER
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $606,796 | $567,905 | $505,604 | $181,229 | N/A |
| Gross Profit | $480,559 | $343,019 | $388,148 | $128,642 | N/A |
| Gross Margin | 79.2% | 60.4% | 76.8% | 71.0% | N/A |
| Operating Income | $-8,979,367 | $-11,640,006 | $-5,565,979 | $-3,356,790 | $-1,768,569 |
| Net Income | $-30,907,505 | $-12,749,262 | $-5,592,743 | $-3,211,485 | $-11,197,642 |
| Net Margin | -5093.6% | -2245.0% | -1106.2% | -1772.1% | N/A |
| EPS | $-0.50 | $-0.22 | $-0.10 | $-3.79 | $-22.63 |
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.
Visit WebsiteEarnings History & Surprises
THEREPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Jan 3, 2025 | — | — | — | — |
Q4 2024 | Nov 13, 2024 | — | — | — | — |
Q3 2024 | Aug 29, 2024 | — | — | — | — |
Q2 2024 | May 20, 2024 | — | — | — | — |
Q1 2024 | Feb 20, 2024 | — | $0.00 | — | — |
Q4 2023 | Dec 27, 2023 | — | — | — | — |
Q3 2023 | Aug 21, 2023 | — | $0.00 | — | — |
Q2 2023 | May 15, 2023 | — | $0.00 | — | — |
Q1 2023 | Feb 21, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 29, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 23, 2022 | — | $-0.00 | — | — |
Q1 2022 | Feb 18, 2022 | — | $-0.00 | — | — |
Q1 2022 | Jan 13, 2022 | — | $-0.00 | — | — |
Q3 2021 | Sep 28, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 27, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 27, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 27, 2021 | — | $-3.43 | — | — |
Q2 2021 | Jun 10, 2021 | — | $-2.04 | — | — |
Q2 2020 | May 15, 2020 | — | $-5.73 | — | — |
Latest News
Frequently Asked Questions about THER
What is THER's current stock price?
What is the analyst price target for THER?
What sector is Theralink Technologies, Inc. in?
What is THER's market cap?
Does THER pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to THER for comparison